Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 906.70
+11.50 (1.28%)
At close: Jul 27, 2026
Fredun Pharmaceuticals Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 6,355 | 6,355 | 4,538 | 3,482 | 2,747 | 2,245 |
Revenue Growth | 40.03% | 40.03% | 30.35% | 26.75% | 22.37% | 67.74% |
Gross Profit Gross Profit Growth | 1,634 | 1,634 | 1,039 | 724.71 | 555.79 | 401.99 |
Operating Income Operating Income Growth | 826.38 | 826.38 | 486.21 | 342.99 | 251.65 | 117.41 |
Net Income Net Income Growth | 326.21 | 326.21 | 197.39 | 156.23 | 108.07 | 63.35 |
Earnings Per Share EPS Growth | 20.41 | 20.41 | 14.17 | 11.22 | 8.04 | 5.09 |
EPS Growth | 43.98% | 43.98% | 26.34% | 39.48% | 58.14% | 202.19% |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
export export Growth | 1,070 | 1,070 | 761.81 | 777.14 | 620.31 | 736.09 |
India India Growth | 5,264 | 5,264 | 3,765 | 2,689 | 2,123 | 1,481 |
Total Total Growth | 6,333 | 6,333 | 4,527 | 3,466 | 2,743 | 2,217 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 649.27 | 649.27 | 51.73 | 21.21 | 34.05 | 21.04 |
Total Debt Total Debt Growth | 2,422 | 2,422 | 1,684 | 1,055 | 865.47 | 606.59 |
Net Cash (Debt) Net Cash Growth | -1,772 | -1,772 | -1,632 | -1,034 | -831.41 | -585.54 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -110.88 | -110.88 | -117.20 | -74.24 | -61.89 | -47.01 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 119.02 | 119.02 | -165.98 | -4.39 | -144.09 | -23.8 |
Capital Expenditures CapEx Growth | -735.91 | -735.91 | -61.06 | -76.39 | -94.95 | -42.86 |
Free Cash Flow Free Cash Flow Growth | -616.89 | -616.89 | -227.04 | -80.78 | -239.03 | -66.66 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 25.71% | 25.71% | 22.90% | 20.82% | 20.23% | 17.91% |
Operating Margin | 13.00% | 13.00% | 10.71% | 9.85% | 9.16% | 5.23% |
Pretax Margin | 7.40% | 7.40% | 6.06% | 6.16% | 6.37% | 3.83% |
Profit Margin | 5.13% | 5.13% | 4.35% | 4.49% | 3.93% | 2.82% |
FCF Margin | -9.71% | -9.71% | -5.00% | -2.32% | -8.70% | -2.97% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.233 | 0.233 | 0.233 | 0.233 | 0.233 | 0.233 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 0.03% | 0.04% | 0.10% | 0.10% | 0.09% | 0.08% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 28, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 44.43 | 24.75 | 15.92 | 21.58 | 33.05 | 64.04 |
PS Ratio | 2.36 | 1.27 | 0.69 | 0.97 | 1.30 | 1.81 |